|
PPFIBP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.373600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.017900E-03 |
| Normal-vs-Stage2 |
1.415100E-03 |
| Normal-vs-Stage3 |
1.364660E-03 |
| Normal-vs-Stage4 |
1.772650E-04 |
| Stage1-vs-Stage2 |
2.229400E-01 |
| Stage1-vs-Stage3 |
5.335000E-01 |
| Stage1-vs-Stage4 |
1.639030E-01 |
| Stage2-vs-Stage3 |
4.851600E-01 |
| Stage2-vs-Stage4 |
8.770000E-01 |
| Stage3-vs-Stage4 |
4.987000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.565600E-04 |
| Normal-vs-AfricanAmerican |
2.377800E-01 |
| Normal-vs-Asian |
4.549000E-01 |
| Caucasian-vs-AfricanAmerican |
2.698600E-01 |
| Caucasian-vs-Asian |
1.890230E-02 |
| AfricanAmerican-vs-Asian |
6.218000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.32770000005333E-06 |
| Normal-vs-Female |
4.459000E-03 |
| Male-vs-Female |
9.544600E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.524450E-02 |
| Normal-vs-Age(41-60Yrs) |
2.304600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.7137399999978E-05 |
| Normal-vs-Age(81-100Yrs) |
2.741400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.094000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.834370E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.517800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.105800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.405760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.426000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.063000E-01 |
| Classical-VS-Follicular |
2.588300E-04 |
| Classical-VS-Other |
3.701700E-02 |
| Classical-VS-Normal |
1.853760E-02 |
| Tall-VS-Follicular |
2.964400E-01 |
| Tall-VS-Other |
1.332180E-01 |
| Tall-VS-Normal |
4.396200E-03 |
| Follicular-VS-Other |
4.179400E-01 |
| Follicular-VS-Normal |
4.61569999998801E-06 |
| Other-VS-Normal |
3.259200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.757800E-04 |
| Normal-vs-N1 |
7.297400E-03 |
| N0-vs-N1 |
6.190600E-01 |
|
|
